These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24313016)

  • 21. [Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient].
    Ronco P; Debiec H
    Biol Aujourdhui; 2013; 207(4):249-59. PubMed ID: 24594573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antenatal membranous glomerulonephritis with vascular injury induced by anti-neutral endopeptidase antibodies: toward new concepts in the pathogenesis of glomerular diseases.
    Debiec H; Guigonis V; Mougenot B; Haymann JP; Bensman A; Deschênes G; Ronco PM
    J Am Soc Nephrol; 2003 Jun; 14 Suppl 1():S27-32. PubMed ID: 12761235
    [No Abstract]   [Full Text] [Related]  

  • 23. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
    Ronco P; Debiec H
    Pflugers Arch; 2017 Aug; 469(7-8):997-1005. PubMed ID: 28597189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2010 Apr; 21(4):564-9. PubMed ID: 20185638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podocyte antigens and glomerular disease.
    Ronco P; Debiec H
    Nephron Exp Nephrol; 2007; 107(2):e41-6. PubMed ID: 17726340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
    Ronco P; Debiec H
    Semin Immunopathol; 2007 Nov; 29(4):445-58. PubMed ID: 17899086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides.
    King KA; Hua J; Torday JS; Drazen JM; Graham SA; Shipp MA; Sunday ME
    J Clin Invest; 1993 May; 91(5):1969-73. PubMed ID: 8486767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune tolerance of mother against fetus and placenta].
    Donat H
    Allerg Immunol (Leipz); 1986; 32(2):79-86. PubMed ID: 2425616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal and fetal immune responses during pregnancy.
    Sargent IL
    Exp Clin Immunogenet; 1993; 10(2):85-102. PubMed ID: 8251183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in membranous nephropathy: success stories of a long journey.
    Ronco P; Debiec H
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):460-6. PubMed ID: 21388432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation.
    Sunday ME; Hua J; Torday JS; Reyes B; Shipp MA
    J Clin Invest; 1992 Dec; 90(6):2517-25. PubMed ID: 1469102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequestration of anti-Cra in the placenta: serologic demonstration by placental elution.
    Weber SL; Bryant BJ; Indrikovs AJ
    Transfusion; 2005 Aug; 45(8):1327-30. PubMed ID: 16078921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Placental immunoglobulin transfer].
    Elefant E
    Bull Acad Natl Med; 2012 Nov; 196(8):1601-12. PubMed ID: 24313015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The secretory immune system as part of the placental barrier in the second trimester of pregnancy in humans.
    Ben-Hur H; Gurevich P; Berman V; Tchanyshev R; Gurevich E; Zusman I
    In Vivo; 2001; 15(5):429-35. PubMed ID: 11695242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological aspects of pregnancy].
    Vinatier D; Monnier JC; Dessaint JP
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(1):1-10. PubMed ID: 6853968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of anti-HPL in fetal, placental, and maternal renal tissues.
    Gudson JP; Caudle MR; Herbst GA
    Gynecol Invest; 1975; 6(6):321-8. PubMed ID: 1243548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal growth modified by natural and induced changes in maternal reactivity.
    Breyere EJ
    Cancer Res; 1976 Sep; 36(9 PT 2):3441-5. PubMed ID: 975102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is fetal microchimerism beneficial for the fetus or the mother].
    Boyon C; Collinet P; Boulanger L; Vinatier D
    Gynecol Obstet Fertil; 2011 Apr; 39(4):224-31. PubMed ID: 21429781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why didn't your mother reject you?
    Wegmann TG
    Can Med Assoc J; 1980 Nov; 123(10):991-3. PubMed ID: 7448674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.